The RACer system is being developed to reduce the symptoms, such as nasal air-way drying, associated with the use pressurised breathing therapies such as CPAP. We anticipate that this will improve comfort, adherence and compliance to such therapies.


Complete prototype, obtain clinical validation and commercialise through licensing.

Unique Selling Propositions
  • Improve adherence and compliance to CPAP therapies by improving comfort and relieving symptoms of pressurised air.
  • Greater comfort and adherence increases the uptake, hence sales of the products for sleep-apnea therapy supplier.

The RACer system is currently developed for the treatment of sleep apnea. Other potential applications include cognitive therapy, depression treatment, sport performance and recovery, stroke rehabiliation, diabetes, stress etc.

IP Strategy

Patent, trade secrets, and know-how.

Project Status

Proof of Concept - Early prototype built